Back to search

Article

Concordance Between WHO 2022 and ICC 2022 Classifications of Myeloid Neoplasms: A Single-Center Clinicopathological and Molecular Analysis

2026-05-15

Abstract excerpt

<title>Abstract</title> <p>The simultaneous publication of the 5th edition World Health Organization (WHO 2022) and International Consensus Classification (ICC 2022) systems for myeloid neoplasms raised concerns about divergent diagnoses in clinical practice. We retrospectively classified 71 consecutive patients with myeloid neoplasms (myelodysplastic syndromes [MDS], n=34; chronic myelomonocytic leukemia [CMML],...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d7a96831-9524-5661-8c24-d7de583f265f
DOI
10.21203/rs.3.rs-9569530/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Concordance Between WHO 2022 and ICC 2022 Classifications of Myeloid Neoplasms: A Single-Center Clinicopathological and Molecular AnalysisDOI 10.21203/rs.3.rs-9569530/v1
Navigating diagnostic shifts: A comparative review of the WHO 5th edition and ICC 2022 classifications of myeloid neoplasms.Semantic proximity
Reclassification of Myelodysplastic Neoplasms According to the 2022 World Health Organization Classification and the 2022 International Consensus Classification Using Open-Source Data: Focus on SF3B1- and TP53-mutated Myelodysplastic Neoplasms.Semantic proximity
Implications of the 5th Edition of the World Health Organization Classification and International Consensus Classification of Myeloid Neoplasm in Myelodysplastic Syndrome With Excess Blasts and Acute Myeloid Leukemia.Semantic proximity
Comparison of the 2022 World Health Organization Classification and International Consensus Classification in Myelodysplastic Syndromes/NeoplasmsSemantic proximity
Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms.Semantic proximity
Acute Myeloid Leukemia and Myelodysplastic Neoplasms: Clinical Implications of Myelodysplasia-Related Genes Mutations and TP53 AberrationsSemantic proximity
Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.Semantic proximity
Comparative Analysis of ICC and WHO Classifications Reveals Molecular and Clinical Convergence Between AML-MR and MDS/AML.Semantic proximity
Molecular landscape of myelodysplastic neoplasms in disease classification and prognostication.Semantic proximity
The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms.Semantic proximity
Perspectives on Acute Myeloid Leukemia Diagnosis: A Comparative Analysis of the Latest World Health Organization and the International Consensus ClassificationsSemantic proximity
AML classification in the year 2023: How to avoid a Babylonian confusion of languages.Semantic proximity
Select a neighboring publication to make it the new centre.